- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...
- - This release is not intended for US and Canadian media ...
- Results from CLARIFY, the largest international registry ever ...
-Analysis evaluated efficacy and safety among three patient sub-groups A new ...
- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg ...
- Broadens later stage capabilities and Increases Asian ...